by IR Team | Sep 17, 2020 | News
By HospiMedica International staff writers Posted on 17 Sep 2020 A new rapid diagnostic test is expected to be the market’s first COVID-19 rapid diagnostic test for measuring the levels of functional SARS-CoV-2 neutralizing antibodies in a lateral flow assay format....
by IR Team | Sep 16, 2020 | News
San Diego-based Axim Biotechnologies Inc., an international health care solutions company targeting oncological and COVID-19 research, has filed an emergency use authorization (EUA) application with the U.S. FDA for measuring COVID-19 neutralizing antibodies in plasma...
by IR Team | Sep 16, 2020 | Press Release
SAN DIEGO – September 16, 2020 – AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has filed an Emergency Use...
by IR Team | Aug 30, 2020 | Audio
John Huemoeller, CEO of AXIM Biotechnologies, discusses his company’s recently announced COVID-19 test that aims to speed up the COVID testing process that would, hopefully, lead to a COVID-19 vaccine more quickly. Huemoeller chats about AXIM’s pivot into cancer care....
by IR Team | Aug 24, 2020 | Press Release
SAN DIEGO, August 24, 2020 — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the Company has signed an exclusive...
